133 related articles for article (PubMed ID: 36040037)
1. Clinicopathologic and Prognostic Features of Pediatric Follicular Cell-derived Thyroid Carcinomas: A Retrospective Study of 222 Patients.
Saliba M; Alzumaili BA; Katabi N; Dogan S; Tuttle RM; Zoltan A; Pandit-Taskar N; Xu B; Ghossein RA
Am J Surg Pathol; 2022 Dec; 46(12):1659-1669. PubMed ID: 36040037
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.
Akaishi J; Sugino K; Kameyama K; Masaki C; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Shimizu K; Ito K
World J Surg; 2015 Jul; 39(7):1728-35. PubMed ID: 25743484
[TBL] [Abstract][Full Text] [Related]
3. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
4. Papillary thyroid carcinoma tall cell subtype (PTC-TC) and high-grade differentiated thyroid carcinoma tall cell phenotype (HGDTC-TC) have different clinical behaviour: a retrospective study of 1456 patients.
Ghossein R; Katabi N; Dogan S; Shaha AR; Tuttle RM; Fagin JA; Ganly I; Xu B
Histopathology; 2024 Jun; 84(7):1130-1138. PubMed ID: 38528726
[TBL] [Abstract][Full Text] [Related]
5. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.
Thompson LD; Wieneke JA; Heffess CS
Endocr Pathol; 2005; 16(4):331-48. PubMed ID: 16627920
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Prognoses for pT3 Papillary Thyroid Carcinomas and Impact of Delayed Risk Stratification.
Tavarelli M; Sarfati J; Chereau N; Tissier F; Golmard JL; Ghander C; Lussey-Lepoutre C; Trésallet C; Menegaux F; Leenhardt L; Buffet C
Thyroid; 2017 Jun; 27(6):778-786. PubMed ID: 28351220
[TBL] [Abstract][Full Text] [Related]
9. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
Wong KS; Strickland KC; Angell TE; Nehs MA; Alexander EK; Cibas ES; Krane JF; Howitt BE; Barletta JA
Endocr Pathol; 2017 Jun; 28(2):171-176. PubMed ID: 28271380
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
11. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Diffuse Sclerosing Variant Papillary Thyroid Carcinoma in Pediatric Patients.
Brady C; Manning SC; Rudzinski E; Paulson V; Wang X; Liu YJ; Parikh SR; Bonilla-Velez J; Hawkins DS; Dahl J
Laryngoscope; 2022 May; 132(5):1132-1138. PubMed ID: 34713899
[TBL] [Abstract][Full Text] [Related]
13. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution.
Lam AK; Lo CY
Ann Surg Oncol; 2006 Feb; 13(2):176-81. PubMed ID: 16411146
[TBL] [Abstract][Full Text] [Related]
14. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study.
Kim M; Cho SW; Park YJ; Ahn HY; Kim HS; Suh YJ; Choi D; Kim BK; Yang GE; Park IS; Yi KH; Jung CK; Kim BH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):619-627. PubMed ID: 34107674
[TBL] [Abstract][Full Text] [Related]
16. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
[No Abstract] [Full Text] [Related]
17. Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
Ragazzi M; Besutti G; Mancuso P; Rossi PG; Ciarrocchi A; Donati B; Manzotti G; Giordano D; Frasoldati A; Chiaruccci F; de de Biase D; Coluccelli S; Maloberti T; De Leo A; Piana S; Tallini G
Histopathology; 2024 Jul; 85(1):62-74. PubMed ID: 38477417
[TBL] [Abstract][Full Text] [Related]
18. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.
Ghossein RA; Leboeuf R; Patel KN; Rivera M; Katabi N; Carlson DL; Tallini G; Shaha A; Singh B; Tuttle RM
Thyroid; 2007 Jul; 17(7):655-61. PubMed ID: 17696836
[TBL] [Abstract][Full Text] [Related]
19. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
[TBL] [Abstract][Full Text] [Related]
20. Follicular and Diffuse Sclerosing Variant Papillary Thyroid Carcinomas as Independent Predictive Factors of Loco-Regional Recurrence: A Comparison Study Using Propensity Score Matching.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2016 Aug; 26(8):1077-84. PubMed ID: 27324748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
